Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
0.8573
+0.0306 (3.70%)
At close: Sep 9, 2025, 4:00 PM
0.8988
+0.0415 (4.84%)
Pre-market: Sep 10, 2025, 7:15 AM EDT

Immunic Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2020
85906862251317
Upgrade
Market Cap Growth
-33.16%33.02%9.04%-75.28%-20.70%222.80%
Upgrade
Enterprise Value
30329-10142185
Upgrade
Last Close Price
0.861.001.501.409.5715.29
Upgrade
PB Ratio
2.494.892.340.551.982.00
Upgrade
P/TBV Ratio
2.494.892.340.552.672.52
Upgrade
Debt / Equity Ratio
0.030.050.050.010.010.01
Upgrade
Quick Ratio
2.051.641.999.107.8115.37
Upgrade
Current Ratio
2.191.772.129.639.2115.93
Upgrade
Return on Equity (ROE)
-208.93%-424.44%-131.28%-100.01%-65.02%-40.54%
Upgrade
Return on Assets (ROA)
-88.95%-128.79%-68.13%-40.53%-30.30%-26.18%
Upgrade
Return on Capital (ROIC)
-132.35%-246.62%-85.24%-44.44%-32.31%-28.00%
Upgrade
Earnings Yield
-120.41%-111.58%-138.24%-193.89%-37.00%-13.89%
Upgrade
FCF Yield
-106.75%-94.39%-105.09%-105.08%-33.16%-14.61%
Upgrade
Buyback Yield / Dilution
-50.88%-126.03%-39.29%-34.52%-51.00%-102.84%
Upgrade
Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q